154 related articles for article (PubMed ID: 27981643)
1. UGT1A1 (TA)
Joly P; Renoux C; Lacan P; Bertrand Y; Cannas G; Garnier N; Cuzzubbo D; Kebaïli K; Renard C; Gauthier A; Pialoux V; Martin C; Romana M; Connes P
Eur J Haematol; 2017 Mar; 98(3):296-301. PubMed ID: 27981643
[TBL] [Abstract][Full Text] [Related]
2. Association of UGT1A1 polymorphism with prevalence and age at onset of cholelithiasis in sickle cell anemia.
Chaar V; Kéclard L; Diara JP; Leturdu C; Elion J; Krishnamoorthy R; Clayton J; Romana M
Haematologica; 2005 Feb; 90(2):188-99. PubMed ID: 15710570
[TBL] [Abstract][Full Text] [Related]
3. Early modification of sickle cell disease clinical course by UDP-glucuronosyltransferase 1A1 gene promoter polymorphism.
Martins R; Morais A; Dias A; Soares I; Rolão C; Ducla-Soares JL; Braga L; Seixas T; Nunes B; Olim G; Romão L; Lavinha J; Faustino P
J Hum Genet; 2008; 53(6):524-528. PubMed ID: 18392554
[TBL] [Abstract][Full Text] [Related]
4. Uridine diphosphate glucuronosyl transferase 1A (UGT1A1) promoter polymorphism in young patients with sickle cell anaemia: report of the first cohort study from Nigeria.
Olatunya OS; Albuquerque DM; Akanbi GO; Aduayi OS; Taiwo AB; Faboya OA; Kayode TS; Leonardo DP; Adekile A; Costa FF
BMC Med Genet; 2019 Oct; 20(1):160. PubMed ID: 31619193
[TBL] [Abstract][Full Text] [Related]
5. Influence of UGT1A1 promoter polymorphism, α-thalassemia and β
Batista JVGF; Arcanjo GS; Batista THC; Sobreira MJ; Santana RM; Domingos IF; Hatzlhofer BL; Falcão DA; Pereira-Martins DA; Oliveira JM; Araujo AS; Laranjeira LPM; Medeiros FS; Albuquerque FP; Albuquerque DM; Santos MN; Hazin MF; Dos Anjos AC; Costa FF; Araujo AS; Lucena-Araujo AR; Bezerra MA
Ann Hematol; 2021 Apr; 100(4):903-911. PubMed ID: 33523291
[TBL] [Abstract][Full Text] [Related]
6. UGT1A1 polymorphism outweighs the modest effect of deletional (-3.7 kb) alpha-thalassemia on cholelithogenesis in sickle cell anemia.
Chaar V; Kéclard L; Etienne-Julan M; Diara JP; Elion J; Krishnamoorthy R; Romana M
Am J Hematol; 2006 May; 81(5):377-9. PubMed ID: 16628735
[TBL] [Abstract][Full Text] [Related]
7. Early complication in sickle cell anemia children due to A(TA)nTAA polymorphism at the promoter of UGT1A1 gene.
Chaouch L; Talbi E; Moumni I; Ben Chaabene A; Kalai M; Chaouachi D; Mallouli F; Ghanem A; Abbes S
Dis Markers; 2013; 35(2):67-72. PubMed ID: 24167350
[TBL] [Abstract][Full Text] [Related]
8. Do Alpha Thalassemia, Fetal Hemoglobin, and the UGT1A1 Polymorphism have an Influence on Serum Bilirubin Levels and Cholelithiasis in Patients with Sickle Cell Disease?
de Azevedo LA; Bonazzoni J; Wagner SC; Farias MG; Bittar CM; Daudt L; de Castro SM
Mol Diagn Ther; 2017 Aug; 21(4):437-442. PubMed ID: 28567595
[TBL] [Abstract][Full Text] [Related]
9. The linear effects of alpha-thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease.
Vasavda N; Menzel S; Kondaveeti S; Maytham E; Awogbade M; Bannister S; Cunningham J; Eichholz A; Daniel Y; Okpala I; Fulford T; Thein SL
Br J Haematol; 2007 Jul; 138(2):263-70. PubMed ID: 17593033
[TBL] [Abstract][Full Text] [Related]
10. Influence of bilirubin uridine diphosphate-glucuronosyltransferase 1A promoter polymorphisms on serum bilirubin levels and cholelithiasis in children with sickle cell anemia.
Passon RG; Howard TA; Zimmerman SA; Schultz WH; Ware RE
J Pediatr Hematol Oncol; 2001 Oct; 23(7):448-51. PubMed ID: 11878580
[TBL] [Abstract][Full Text] [Related]
11. Influence of beta-cluster haplotypes, alpha-gene status and UGTA1 polymorphism on clinical and hematological data in sickle-cell disease children from French Guiana.
Elenga N; Cuadro-Alvarez E; Martin E; Njuieyon F; Defo A; Maniassom C
PLoS One; 2020; 15(9):e0238691. PubMed ID: 32881938
[TBL] [Abstract][Full Text] [Related]
12. UGT1A1 promoter polymorphisms and the development of hyperbilirubinemia and gallbladder disease in children with sickle cell anemia.
Carpenter SL; Lieff S; Howard TA; Eggleston B; Ware RE
Am J Hematol; 2008 Oct; 83(10):800-3. PubMed ID: 18756540
[TBL] [Abstract][Full Text] [Related]
13. UGT1A1 promoter polymorphism associated with serum bilirubin level in Saudi patients with sickle cell disease.
Hamad Z; Aljedai A; Halwani R; AlSultan A
Ann Saudi Med; 2013; 33(4):372-6. PubMed ID: 24060717
[TBL] [Abstract][Full Text] [Related]
14. The effect of UGT1A1 promoter polymorphism in the development of hyperbilirubinemia and cholelithiasis in hemoglobinopathy patients.
AlFadhli S; Al-Jafer H; Hadi M; Al-Mutairi M; Nizam R
PLoS One; 2013; 8(10):e77681. PubMed ID: 24204915
[TBL] [Abstract][Full Text] [Related]
15. UGT1A promoter polymorphisms influence bilirubin response to hydroxyurea therapy in sickle cell anemia.
Heeney MM; Howard TA; Zimmerman SA; Ware RE
J Lab Clin Med; 2003 Apr; 141(4):279-82. PubMed ID: 12677174
[TBL] [Abstract][Full Text] [Related]
16. The influence of uridine diphosphate glucuronosyl transferase 1A promoter polymorphisms, beta-globin gene haplotype, co-inherited alpha-thalassemia trait and Hb F on steady-state serum bilirubin levels in sickle cell anemia.
Adekile A; Kutlar F; McKie K; Addington A; Elam D; Holley L; Clair B; Kutlar A
Eur J Haematol; 2005 Aug; 75(2):150-5. PubMed ID: 16004608
[TBL] [Abstract][Full Text] [Related]
17. Genetic link with cholelithiasis among pediatric SCA Tunisian patients: Examples of UGT1A1, SLCO1A2 and SLCO1B1.
Chaouch L; Kalai1 M; Darragi I; Boudrigua I; Chaouachi D; Ammar SB; Mellouli F; Bjaoui M; Abbes S
Hematology; 2016 Mar; 21(2):121-5. PubMed ID: 26146896
[TBL] [Abstract][Full Text] [Related]
18. The role of rs1984112_G at CD36 gene in increasing reticulocyte level among sickle cell disease patients.
Kalai M; Dridi M; Chaouch L; Moumni I; Ouragini H; Darragi I; Boudrigua I; Chaouachi D; Mellouli F; Bejaoui M; Abbes S
Hematology; 2017 Apr; 22(3):178-182. PubMed ID: 27869039
[TBL] [Abstract][Full Text] [Related]
19. Gilbert syndrome acts as a risk factor of developing gallstone among β hemoglobinopathy Tunisian patients.
Chaouch L; Kalai M; Chaouachi D; Mallouli F; Hafsia R; Ben Ammar S; Abbes S
Tunis Med; 2015 Apr; 93(4):237-41. PubMed ID: 26375741
[TBL] [Abstract][Full Text] [Related]
20. UGT1A1 (TA)n genotyping in sickle-cell disease: high resolution melting (HRM) curve analysis or direct sequencing, what is the best way?
Thomas V; Mazard B; Garcia C; Lacan P; Gagnieu MC; Joly P
Clin Chim Acta; 2013 Sep; 424():258-60. PubMed ID: 23827693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
